I think it is impossible to guess in any meaningful way,

New Post Public Reply Private Reply Replies (1) Message Board
craigakess Riztheinvestor #129571
467
I think it is impossible to guess in any meaningful way, given that we have barely any facts to go on as to where CYDY is in the whole process with the FDA, but if pressed to guess, I would say no, the hold will not be lifted by the end of the year. Before anyone gets all upset, hear me out and let me know if you think something is wrong with this logic.

CYDY says it submitted "a first series of documents" to the FDA in September. That is very vague as to how many series of documents must be submitted and how much longer they think they will take to be submitted. Then, one has to factor in that this is just one of many things the FDA is working on, so how long does it take for review of each series of documents? A week? 90 days? We have no idea, as far as I know, but again the first series was submitted a month ago and to the best of our knowledge, we have heard nothing from the FDA as of yet.

And once submitted, even if reviewed by the FDA, will they all be accepted "as-is" or will revisions be needed? We hope they will be accepted, of course, but to bet that any company would get it all right the first time could be a big ask.

I hope CYDY keeps shareholders and potential shareholders up to date with the FDA process, but I have no idea how/when/if they plan to communicate except for quarterly meetings.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Jushi Holdings Inc. Prepares for Upcoming Financial Results Call

Updated Category News Views 84

Jushi Holdings Inc. to Announce Financial Results BOCA RATON, Fla. -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a well-established player in the cannabis industry, is gearing up to share its financial performance for the second quarter. This key announcement will take place after market hours on the fifth day of August. Details for...

Continue Reading
Mike Tyson Partners with BoltBetz to Innovate Cashless Gaming

Updated Category News Views 258

Mike Tyson's Exciting Role with BoltBetz BoltBetz, known for revolutionizing cashless gaming technology, has recently announced a significant partnership with the legendary boxing champion Mike Tyson. With Tyson as both a strategic investor and promotional partner, this collaboration promises to transform the landscape of gaming across various casinos. Tyson's entry into...

Continue Reading
Portage Community Bank Welcomes C. Joseph Assid as CFO

Updated Category News Views 233

Portage Community Bank Appoints New Executive Leader Portage Community Bank is thrilled to announce the appointment of C. Joseph Assid as the new Executive Vice President and Chief Financial Officer. With a rich experience spanning over twenty-five years in financial institution accounting, audit, and assurance services, Mr. Assid brings invaluable expertise to this...

Continue Reading
Angelalign Faces Patent Battle with Align in China

Updated Category News Views 7

Angelalign Technology Inc., listed as 6699.HK on the Hong Kong Stock Exchange, is heading back to court—this time, challenging a ruling from the Jinan Intermediate People's Court in China. They aim to overturn a judgment that ordered their subsidiaries to stop using key systems like the masterForce biomechanics simulation and the ATreat digital diagnosis system for...

Continue Reading
Unicycive Therapeutics Investors Encouraged to Act Now

Updated Category News Views 90

Unicycive Therapeutics Investigated for Potential Claims Investors holding securities in Unicycive Therapeutics, Inc. are facing an important deadline for potential legal actions. The company, listed on NASDAQ as UNCY, has come under scrutiny, and it's essential for affected investors to understand their options moving forward. Who Should Be Concerned? If you acquired...

Continue Reading